
Supplements and Featured Publications
- Glaucoma 360: Highlights from 2020
Glaucoma 360: Lowering IOP using the MIMS solution
ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.
ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma called MIMS — Minimally Invasive Micro Sclerostomy — solution, designed to create a single-patient-use sterile tool and a multi-use external machine, during the 2020 Glaucoma 360 meeting in San Francisco, California.
Articles in this issue
about 5 years ago
Assessing the angle: Getting back to basicsabout 5 years ago
OCTA: The jury is still outabout 5 years ago
Funding new technologies for glaucoma treatmentabout 5 years ago
Glaucoma drug delivery devices enter new frontierabout 5 years ago
Glaucoma devices: Now and in the futureabout 5 years ago
Beating burnout with camaraderieabout 5 years ago
Status of glaucoma: diagnostics and treatments in fluxabout 5 years ago
Next frontier in glaucoma: Beyond IOP-lowering treatmentsabout 5 years ago
Normal tension glaucoma: testing diagnostic skillsabout 5 years ago
Diagnostics: Innovative ways of looking at glaucomaNewsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.